Workshop A: Unlocking the Potential of the Suprachoroidal Space to Deliver Durable Ophthalmic Therapies

Time: 9:00 am - 12:00 pm
day: Pre-Conference Workshop Day


Suprachoroidal delivery is an emerging and exciting alternative administration route to increase

the durability of different ophthalmic therapies. The recent FDA approval of the first therapeutic

delivered into the suprachoroidal space is leading the charge of an array of ongoing preclinical

and clinical developments using suprachoroidal delivery for a range of ophthalmic modalities

and indications. Join this workshop to hear the latest developments from Clearside Biomedical on

this exciting area of ophthalmic delivery.

Highlights include:

  • Accessing the suprachoroidal space to unlock sustained therapeutic durability
  • Exploring the ongoing potential of suprachoroidal injections to deliver small molecule and gene therapy treatments
  • Upscaling training and simplifying procedures to widen suprachoroidal injection accessibility